Get started
Author

Edith A. Nutescu

Observed names: E A Nutescu, E NUTESCU, E Nutescu, E. A Nutescu, E. A. Nutescu, E. Nutescu, E.A. Nutescu, EA Nutescu, Edith A Nutescu, Edith Nutescu, Nutescu, E.A., Nutescu, Edith A.
Observed institutions: University of Illinois Urbana-Champaign, Loyola University Chicago, Advocate Lutheran General Hospital, University of Florida, University of Illinois Chicago, University of Illinois Hospital & Health Sciences System, Amsterdam University Medical Centers, Ortho-McNeil Pharmaceutical (United States), University of Nebraska Medical Center, Fuzhou University
ORCID: 0000-0002-2651-0020
Observed ORCID: 0000-0002-2651-0020
OpenAlex ID: A5084577356
Mapping the human genetic architecture of COVID-19
2021 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics InitiativeLeadership, et al. · Nature · 983
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
2006 · Harumi Takahashi, Grant R. Wilkinson, et al. · Pharmacogenetics and Genomics · 376
PDF
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
2017 · Larisa H. Cavallari, Craig R. Lee, et al. · JACC: Cardiovascular Interventions · 313
PDF
Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings
2009 · Edith A Nutescu, Sarah A Spinier, et al. · Annals of Pharmacotherapy · 289
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
2013 · Minoli A Perera, Larisa H Cavallari, et al. · The Lancet · 276
PDF
Drug and dietary interactions of warfarin and novel oral anticoagulants: an update
2011 · Edith Nutescu, Ittiporn Chuatrisorn, et al. · Journal of Thrombosis and Thrombolysis · 244
Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans
2010 · L H Cavallari, T Y Langaee, et al. · Clinical Pharmacology & Therapeutics · 196
Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes
2007 · Adam J. Duhl, Michael J. Paidas, et al. · American Journal of Obstetrics and Gynecology · 184
Pharmacology of anticoagulants used in the treatment of venous thromboembolism
2016 · Edith A. Nutescu, Allison Burnett, et al. · Journal of Thrombosis and Thrombolysis · 166
PDF
Warfarin and its interactions with foods, herbs and other dietary supplements
2006 · Edith A Nutescu, Nancy L Shapiro, et al. · Expert Opinion on Drug Safety · 149
Dosing and Monitoring of Low‐Molecular‐Weight Heparins in Special Populations
2001 · Beth A. Duplaga, Christina W. Rivers, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 137
Factors that Influence Prescribing Decisions
2004 · Glen T Schumock, Surrey M Walton, et al. · Annals of Pharmacotherapy · 128
Practical Management of Anticoagulation in Patients With Atrial Fibrillation
2015 · Richard J. Kovacs, Greg C. Flaker, et al. · Journal of the American College of Cardiology · 111
PDF
Ezetimibe: A Selective Cholesterol Absorption Inhibitor
2003 · Edith A. Nutescu, Nancy L. Shapiro · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 109
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
2008 · David A Garcia, Daniel M Witt, et al. · Annals of Pharmacotherapy · 105
Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans
2014 · Katarzyna Drozda, Shan Wong, et al. · Pharmacogenetics and Genomics · 100
Rivaroxaban: An oral direct inhibitor of factor Xa
2008 · Michael P. Gulseth, Jessica Michaud, et al. · American Journal of Health-System Pharmacy · 95
Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges
2016 · MJ Arwood, S Chumnumwat, et al. · Clinical and Translational Science · 92
PDF
Quality of Pharmacist-Managed Anticoagulation Therapy in Long-Term Ambulatory Settings: A Systematic Review
2017 · Beenish S. Manzoor, Wei-Han Cheng, et al. · Annals of Pharmacotherapy · 88
Real‐World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation
2017 · Beenish S. Manzoor, Todd A. Lee, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 88
Decreased Warfarin Clearance Associated With the CYP2C9 R150H (*8) Polymorphism
2012 · Y Liu, H Jeong, et al. · Clinical Pharmacology & Therapeutics · 87
PDF
Feasibility of Implementing a Comprehensive Warfarin Pharmacogenetics Service
2013 · Edith A. Nutescu, Katarzyna Drozda, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 82
Factors Influencing Warfarin Dose Requirements in African–Americans
2007 · Kathryn M Momary, Nancy L Shapiro, et al. · Pharmacogenomics · 76
Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin
2005 · Sarah A Spinler, Ann K Wittkowsky, et al. · Annals of Pharmacotherapy · 67
Daily Hospitalization Costs in Patients with Deep Vein Thrombosis or Pulmonary Embolism Treated with Anticoagulant Therapy
2014 · Joseph F. Dasta, Dominic Pilon, et al. · Thrombosis Research · 66
Works count: 275
Citation count: 7,415
H-index: 40
I10-index: 121
Year
Topic
Type